DK1858861T3 - HIV-inhiberende 2-(4-cyanophenyl)-6-hydroxylaminopyrimidiner - Google Patents

HIV-inhiberende 2-(4-cyanophenyl)-6-hydroxylaminopyrimidiner

Info

Publication number
DK1858861T3
DK1858861T3 DK06708609.0T DK06708609T DK1858861T3 DK 1858861 T3 DK1858861 T3 DK 1858861T3 DK 06708609 T DK06708609 T DK 06708609T DK 1858861 T3 DK1858861 T3 DK 1858861T3
Authority
DK
Denmark
Prior art keywords
hydroxylaminopyrimidines
cyanophenyl
compounds
hiv inhibiting
hiv
Prior art date
Application number
DK06708609.0T
Other languages
English (en)
Inventor
Kock Herman Augustinus De
Piet Piet Tom Bert Paul Wigerinck
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of DK1858861T3 publication Critical patent/DK1858861T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK06708609.0T 2005-03-04 2006-03-02 HIV-inhiberende 2-(4-cyanophenyl)-6-hydroxylaminopyrimidiner DK1858861T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05101707 2005-03-04
PCT/EP2006/060407 WO2006094930A1 (en) 2005-03-04 2006-03-02 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines

Publications (1)

Publication Number Publication Date
DK1858861T3 true DK1858861T3 (da) 2010-11-08

Family

ID=34938904

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06708609.0T DK1858861T3 (da) 2005-03-04 2006-03-02 HIV-inhiberende 2-(4-cyanophenyl)-6-hydroxylaminopyrimidiner

Country Status (20)

Country Link
US (2) US20080214588A1 (da)
EP (1) EP1858861B1 (da)
JP (1) JP5118978B2 (da)
CN (1) CN101133038B (da)
AT (1) ATE473212T1 (da)
AU (1) AU2006222057B2 (da)
BR (1) BRPI0609291B1 (da)
CY (1) CY1111102T1 (da)
DE (1) DE602006015291D1 (da)
DK (1) DK1858861T3 (da)
ES (1) ES2347815T3 (da)
HR (1) HRP20100504T1 (da)
ME (1) ME01229B (da)
MX (1) MX2007010744A (da)
PL (1) PL1858861T3 (da)
PT (1) PT1858861E (da)
RS (1) RS51435B (da)
RU (1) RU2401261C2 (da)
SI (1) SI1858861T1 (da)
WO (1) WO2006094930A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007010051A (es) * 2005-02-18 2007-09-21 Tibotec Pharm Ltd Derivados de oxido de 2-(4-cianofenilamino)pirimidina que inhiben el virus de inmunodeficiencia humana.
KR101475091B1 (ko) 2006-12-13 2014-12-22 에프. 호프만-라 로슈 아게 비뉴클레오시드 역전사 효소 억제제로서 2-(피페리딘-4-일)-4-페녹시- 또는 페닐아미노-피리미딘 유도체
ES2527103T3 (es) * 2009-06-22 2015-01-20 Emcure Pharmaceuticals Limited Procedimiento para la síntesis de etravirina
US8153790B2 (en) 2009-07-27 2012-04-10 Krizmanic Irena Process for the preparation and purification of etravirine and intermediates thereof
CN101993419B (zh) * 2009-08-20 2013-01-16 浙江九洲药业股份有限公司 一种4-[(5-溴-4,6-二氯-2-嘧啶基)氨基]苯甲腈的制备方法
GR1007010B (el) 2009-10-08 2010-10-07 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Ινσουλινοειδη πεπτιδια
WO2011135578A1 (en) 2010-04-28 2011-11-03 Chetan Balar Composition comprising chitin and tinosporin for use in the treatment of viral diseases
WO2013059572A1 (en) 2011-10-19 2013-04-25 Assia Chemical Industries Ltd. Process for the preparation of etravirine and intermediates in the synthesis thereof
AU2021224460A1 (en) 2020-02-19 2022-12-15 Pharmasyntez, Joint Stock Company Pyrimidine-based bicycles as antiviral agents for the treatment and prevention of HIV infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) * 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
EP0862463A1 (en) 1995-11-23 1998-09-09 Janssen Pharmaceutica N.V. Solid mixtures of cyclodextrins prepared via melt-extrusion
KR100658489B1 (ko) * 1998-11-10 2006-12-18 얀센 파마슈티카 엔.브이. Hiv 복제를 억제하는 피리미딘
JP4919566B2 (ja) * 1999-09-24 2012-04-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗ウイルス組成物
EP1282607B1 (en) * 2000-05-08 2015-11-11 Janssen Pharmaceutica NV Prodrugs of hiv replication inhibiting pyrimidines

Also Published As

Publication number Publication date
WO2006094930A1 (en) 2006-09-14
ES2347815T3 (es) 2010-11-04
ATE473212T1 (de) 2010-07-15
CN101133038A (zh) 2008-02-27
JP5118978B2 (ja) 2013-01-16
US20100121060A1 (en) 2010-05-13
US8119801B2 (en) 2012-02-21
US20080214588A1 (en) 2008-09-04
JP2008531658A (ja) 2008-08-14
BRPI0609291B1 (pt) 2022-02-08
CN101133038B (zh) 2012-06-27
PL1858861T3 (pl) 2010-12-31
CY1111102T1 (el) 2015-06-11
RU2007136782A (ru) 2009-04-10
AU2006222057B2 (en) 2012-10-04
EP1858861B1 (en) 2010-07-07
RS51435B (en) 2011-04-30
EP1858861A1 (en) 2007-11-28
RU2401261C2 (ru) 2010-10-10
HRP20100504T1 (hr) 2010-10-31
DE602006015291D1 (de) 2010-08-19
PT1858861E (pt) 2010-09-16
BRPI0609291A2 (pt) 2010-03-09
SI1858861T1 (sl) 2010-10-29
AU2006222057A1 (en) 2006-09-14
ME01229B (me) 2013-06-20
MX2007010744A (es) 2007-09-12

Similar Documents

Publication Publication Date Title
CY1111102T1 (el) 2-(4-κυανοφαινυλ)-6-υδροξυλαμινοπυριμιδινες που αναστελλουν τον hiv
MX2022011365A (es) Derivados de biarilo como inhibidores de la interaccion proteina-proteina de yap/taz-tead.
MX2011012628A (es) Derivados amino-propionicos sustituidos como inhibidores de neprilisina.
HRP20040686B1 (hr) Novi heterocikliäśki spojevi koji djeluju kao inhibitori beta-laktamaza
TW200500346A (en) HIV replication inhibiting indane substituted pyrimidines
MX2011012627A (es) Derivados aminobutiricos sustituidos como inhibidores de nepralisina.
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
EA200602260A1 (ru) Применение замещенных хинолиновых производных для лечения заболеваний, вызываемых микобактериями, резистентными к лекарственным средствам
SE0400284D0 (sv) Novel compounds
NO20090628L (no) Pyridizinon derivativater
NO20083434L (no) Benzamid- og heteroarenderivater
NO20063748L (no) Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
TW200626561A (en) HIV inhibiting 5-substituted pyrimidines
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
SA519410865B1 (ar) مركب حلقي شبيه بكُومارين بوصفه مثبط mek واستخدامه
MX2009010932A (es) Inhibidores no nucleosidos de transcriptasa inversa.
ZA202310682B (en) Nicotinamide ripk1 inhibitors
CR20190545A (es) Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias
EA202091293A1 (ru) Производные пиридинона и их применение в качестве селективных ингибиторов alk-2
EA201290487A1 (ru) 5-амино-4-гидроксипентоиламиды
MX2009013865A (es) Urea y derivados carbamato como inhibidores no nucleosidicos de la transcriptasa inversa.
TN2011000592A1 (en) Substituted aminopropionic derivatives as neprilysin inhibitors
TN2011000593A1 (en) Substituted aminobutyric derivatives as neprilysin inhibitors